| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1281-1288, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
NL McCartney-Francis, DE Mizel, M Frazier-Jessen, AB Kulkarni, JB McCarthy and SM Wahl
Oral Infection and Immunity Branch, National Institute of Dental Research, National Institutes of Health, Bethesda, Maryland, USA.
Mice homozygous for a nonfunctional transforming growth factor-beta 1 gene develop rampant inflammation in vital organs that contributes to a shortened life span. The presence of circulating anti-nuclear anti- bodies, immune deposits in tissues, leukocyte infiltration, and increased major histocompatibility complex antigen expression resembles an autoimmune-like syndrome. One of the overt symptoms that appears in these mice lacking transforming growth factor-beta 1 is the development of dry crusty eyes that close persistently as their health declines. Histologically, the eyes appear normal with little or no inflammation. However, inflammatory lesions, predominantly lymphocytic, develop in the lacrimal glands, disrupting their structure and function and severely limiting their ability to generate tears. This histopathology and aberrant function mimic that of Sjogren's syndrome, a human autoimmune disease characterized by dry eyes and dry mouth. Impeding the leukocyte infiltration into the glands with synthetic fibronectin peptides, which block adhesion, not only prevents the inflammatory pathology but also prevents the persistent eye closure characteristic of these mice.
This article has been cited by other articles:
![]() |
S. Barabino and M. R. Dana Animal Models of Dry Eye: A Critical Assessment of Opportunities and Limitations Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1641 - 1646. [Full Text] [PDF] |
||||
![]() |
N. McCartney-Francis, W. Jin, and S. M. Wahl Aberrant Toll Receptor Expression and Endotoxin Hypersensitivity in Mice Lacking a Functional TGF-{beta}1 Signaling Pathway J. Immunol., March 15, 2004; 172(6): 3814 - 3821. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Thyagarajan, S. Totey, M. J. S. Danton, and A. B. Kulkarni GENETICALLY ALTERED MOUSE MODELS: THE GOOD, THE BAD, ANDTHE UGLY Crit. Rev. Oral. Biol. Med., May 1, 2003; 14(3): 154 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. McCartney-Francis and S. M. Wahl Dysregulation of IFN-{gamma} Signaling Pathways in the Absence of TGF-{beta}1 J. Immunol., November 15, 2002; 169(10): 5941 - 5947. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |